UnitedHealth Reports $113.2B Q4 Revenue Miss, Stock Plunges 20%
UnitedHealth Group’s shares fell 20% after the insurer reported Q4 revenue of $113.2 billion, missing forecasts and posting adjusted EPS of $2.11. The Centers for Medicare & Medicaid Services proposed a nearly flat 0.09% Medicare Advantage rate increase for next year, spurring a sector-wide sell-off.
1. Share Plunge Triggers Sell-Off in Health Insurance Stocks
UnitedHealth Group shares plunged roughly 20% after the company reported quarterly results that fell short of investor expectations and federal regulators announced effectively flat Medicare Advantage rate increases for next year. The Centers for Medicare & Medicaid Services proposed a 0.09% bump in payments for 2027, compared with increases of 5% this year and about 4% in 2025. The combination of disappointing guidance and anemic reimbursement growth sparked a sector-wide decline, with peers Humana, CVS Health and Elevance Health also suffering double-digit losses.
2. Fourth-Quarter Results Highlight Margin Pressure
In the quarter ended December, UnitedHealth reported revenue of $113.2 billion, missing consensus estimates by approximately $600 million, while adjusted earnings per share of $2.11 matched Wall Street forecasts. The company’s medical care ratio rose to 88.9%, up from 85.5% a year earlier, reflecting higher claims costs and weaker Medicare funding. Operating expenses remained elevated, contributing to a 340-basis-point year-over-year increase in combined margin pressure.
3. 2026 Outlook Signals First Revenue Decline in Decades
For 2026, UnitedHealth expects total revenue to exceed $439 billion, a 2% decline from the prior year and its first annual drop in over 30 years. Management attributes this to “planned right-sizing” across the enterprise, including insuring up to 2.8 million fewer members in UnitedHealthcare. The company forecasts adjusted earnings per share above $17.75 and targets a medical care ratio near 88.8%, implying only modest margin recovery despite cost-control initiatives.
4. Investor Implications and Long-Term Considerations
The stock’s worst single-day performance in 25 years highlights growing political and cost-inflation risks confronting the managed care sector. While short-term headwinds may persist—driven by regulatory scrutiny of billing practices and consumer affordability concerns—UnitedHealth’s scale, diversified Optum services and history of returning capital through dividends and buybacks could appeal to long-term investors. Berkshire Hathaway’s sizeable stake underscores confidence in the company’s ability to navigate reimbursement challenges and restore growth over a multi-year horizon.